Medscape Education Continues Its Patient-Centric Mission at EHA 2024
May 29, 2024 | EHA 2024, Patient-centricity, hematology, medical education
Anticipation is building at Medscape Education as the team prepares for the EHA 2024 Congress. Medscape Education is excited to announce a significant presence during the congress including a Medscape booth (#H03) where clinicians are invited to learn about our latest advancements.
In addition to seven accepted abstracts across both benign and malignant hematology, focused on acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), classical Hodgkin lymphoma (cHL), myelofibrosis (MF), multiple myeloma (MM), paroxysmal nocturnal hemoglobinuria (PNH), and congenital thrombotic thrombocytopenic purpura (cTTP), and an ePoster in multiple myeloma — all evidencing the efficacy and impact of its education — Medscape will be hosting three groundbreaking patient-centric symposia. Two of these are in partnership with patient advocacy groups and all three have a patient advocate on the expert faculty panel. This is a landmark achievement for any medical education organization, and one that sits perfectly in helping Medscape’s patient-centric mission.
Integrating the patient voice into disease treatment and patient care is slowly becoming recognized and accepted as a necessary paradigm shift to improve patient outcomes. And Medscape Education, as the leading provider of continuing medical education, has assumed a leadership role in this transformation.
“In line with our mission to humanize healthcare and work collaboratively with patients and global patient advocacy organizations as part of our education planning and execution, I am delighted that we are holding three patient-centric independent satellite symposia at this year’s EHA focused on ALL, CLL and MF,” says Victoria Harvey-Jones, PhD, Associate Director of Clinical Strategy at Medscape Oncology Global. “As part of our expert faculty, we have representatives from the Lymphoma Coalition, the Global MPN Scientific Foundation and the Cancer Support Community. Together, they will all shine a much needed light on the patient perspective, sharing the challenges that people living with blood cancers face and how HCPs can best support them.”
Educating physicians and HCPs on the foundations of patient-centric care—where a patient’s wishes, needs, and concerns are listened to and thoroughly integrated into their treatment plan—has become a priority initiative at Medscape. Last year Medscape collaborated with patient advocates, a global patient advocacy organization, and an expert in psycho-oncology to publish a first-of-its-kind white paper detailing how medical education that integrates patient voices and communication skills alongside crucial disease-oriented education can equip HCPs to open meaningful dialog with their patients and empower them to take a more active role in their treatment.
Medscape’s presentation at the 2023 Patient Centricity & Engagement Conference in Amsterdam was key in providing evidence-based data about how improved HCP-patient communication can smooth the treatment journey for patients and their families, and how education plays a key role in significantly elevating clinician confidence in approaching treatment in a more holistic, patient-centric way.
As a sponsor of the 5th Patient Centricity & Collaboration World Congress in February of this year, Medscape further demonstrated its unwavering commitment to inspiring patient empowerment, and the importance of patient centricity in every aspect of patient care — from R&D of novel treatments to disease management to designing a treatment plan, clinical trial or other health solution. And later this month (20th June), Dr Harvey-Jones will once again present at the Patient Centricity & Engagement Conference in London, leveraging new groundbreaking evidence from Medscape’s patient-centric educational activities that support the need and efficacy for the integration of patient-centric approaches in medical education that can be applied at any and all stages of educational design, from planning to execution.
Medscape Education has a long history—dating back almost 3 decades—as a global leader in providing HCP learners with the most up-to-date medical information. Today, that means taking the lead in CME’s transformation, integrating the patient perspective from planning to execution and ushering in a new healthcare ecosystem that meets and addresses patients as equal partners in their healthcare.“Alongside crucial disease- and treatment-centric conversations as part of our symposia at EHA 2024, our aim is to provide a holistic, all-encompassing approach to education, thereby supporting HCPs to have both knowledgeable and compassionate conversations with their patients,” says Dr Harvey-Jones. “Ultimately, this supports and empowers each person, as well as their family, in shared decision-making, and to live their life as they wish.”
For more information on hematology education at Medscape, please contact Jelena Spyropoulos or Peter Schoonheim.
About Medscape Education Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free accredited CME and CE courses for physicians, nurses, and other healthcare professionals.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Contagious Conversations: Exploring Infectious Disease in the Digital Age
As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...
Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...
Impacting Lives with Rare Disease Education
Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...
Medscape’s Virtual Patient Simulation Makes a Significant Impact on Real-World Treatment Selection for T2D
An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...
A Rare Disease Update from Medscape Education
A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency
New Outcomes Are a Breath of Fresh Air at ERS
ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...
Medscape Education Launches 20th Older Driver Safety Educational Program
Education Supported by the National Highway Traffic Safety Administration
Protecting the Heart Through Education at ESC 2023
Medscape Education Global is joining cardiology professionals from across Europe for ESC 2023 in Amsterdam. This year’s congress theme is “Joining Forces to Protect the Heart,” and Medscape will be...
Medscape’s Rare Disease Learning Center Has Reached 1 Million Learners
The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...
Continuing Medical Education Outcomes are Much More Than Statistical Significance
At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...